RSS   Newsletter   Contact   Advertise with us
Post Online Media

NanoString Technologies appoints Kirk Malloy to board

NanoString TechnologiesNanoString Technologies, a provider of life science tools, announced the appointment of Kirk Malloy, to the company’s board of directors.
Article continues below

READ MORE Organovo appoints Kirk Malloy to board of directors

Dr. Malloy is a senior healthcare executive with more than 20 years of leadership in life science tools, applied markets and molecular diagnostics.

He is currently founder and principal at BioAdvisors, where he provides strategic consulting services to life science, genomic and diagnostic companies.

Dr. Malloy's previous experience includes a 13-year career at Illumina, Inc., where he was most recently Senior Vice President and General Manager of Life Sciences & Applied Markets.

He served as Director of Technical Support at Biosite where he helped build their point-of-care cardiovascular diagnostics test business.

Dr. Malloy also held various management roles at Qiagen N.V., where he helped build the North American commercial organization.

He currently serves as lead director for Organovo Holdings as well as a director for three privately held companies - Edico Genome, iGenomx and Agilome.

Dr. Malloy received his B.S. in Biology and Marine Science from the University of Miami, and his M.S. and Ph.D. in Marine Biology and Biochemistry from the University of Delaware.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy